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Abstract
Background: Despite a global increase in contraception use, its prevalence remains low in low- and middle-income
countries. One strategy to improve uptake and use of contraception, as an essential complement to policies and
supply-side interventions, is demand generation. Demand generation interventions have reportedly produced positive
effects on uptake and use of family planning services, but the evidence base remains poorly documented. To reduce
this knowledge gap, we will conduct a systematic review on the impact of demand generation interventions on the
use of modern contraception. The objectives of the review will be as follows: (1) to synthesize evidence on the impacts
and costs of family planning demand generation interventions and on their effectiveness in improving modern
contraceptive use and (2) to identify the indicators used to assess effectiveness, cost-effectiveness, and impacts of
demand generation interventions.
Methods/design: We will systematically review the public health and health promotion literature in several databases
(e.g., CINAHL, Medline, EMBASE) as well as gray literature. We will select articles from 1970 to 2015, in French and in
English. The review will include studies that assess the impact of family planning programs or interventions on changes
in contraception use. The studied interventions will be those with a demand generation component, even if a supply
component is implemented. Two members of the team will independently search, screen, extract data, and assess the
quality of the studies selected. Different tools will be used to assess the quality of the studies depending on the study
design. If appropriate, a meta-analysis will be conducted. The analysis will involve comparing odd ratios (OR)
Discussion: The systematic review results will be disseminated to United Nations Population Fund program countries
and will contribute to the development of a guidance document and programmatic tools for planning, implementing,
and evaluating demand generation interventions in family planning. Improving the effectiveness of family planning
programs is critical for empowering women and adolescent girls, improving human capital, reducing dependency ratios,
reducing maternal and child mortality, and achieving demographic dividends in low- and middle-income countries.
Systematic review registration: This protocol is registered in PROSPERO (CRD 42015017549).
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use, Low- and middle-income countries, Systematic review, Protocol
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Background
Despite a global increase of approximately 11 % in
the use of modern contraception from 1994 to 2012,
its prevalence remains low in many low-income and
some middle-income countries (LMIC), and especially
in sub-Saharan African countries such as Mali
(9.3 %), Chad (5.5 %), Sierra Leone (7.6 %), and South
Sudan (4.9 %), where its prevalence is under 10 %.
Although progress has been made in Western Asia,
Africa, and Latin America (including the Caribbean),
where contraceptive prevalence rates were estimated
in 2010 at 57.6, 30.9, and 73.2 %, respectively, the un-
met need for contraception is still significant [1], af-
fecting 34.2 % of women in Western Asia, 30 % in
Africa, and 10.4 % in Latin America [2].
Yet an increase in contraception use could prevent up to
one third of maternal deaths [3]. A study assessing the im-
pact of contraceptive use on maternal mortality in 172
countries reported that 342,203 women died of maternal
causes in 2008. Using modeling, that study estimated that
contraception use had prevented 272,040 (uncertainty
interval 127,937–407,134) maternal deaths, and that meet-
ing unmet contraception need could have prevented a fur-
ther 104,000 maternal deaths per year (29 % reduction) [4].
Family planning acts positively on maternal mortality by
reducing the probability of pregnancy and thereby avoiding
its complications, by reducing the risk of unsafe abortions,
and by delaying first pregnancies, especially among adoles-
cents [5].
Family planning programs combine enabling envi-
ronments (policies, strategies, etc.) with both supply
and demand interventions [5]. The objective of
supply-side activities is to ensure the availability, ac-
cessibility, and quality of contraceptive methods for
the population. These activities are often described in
terms of supply-chain management systems, access,
quality, and costs [5]. Some examples of supply-side
interventions are as follows: developing cost-effective
interventions for integrating family planning with ma-
ternal and newborn health, ensuring the availability of
family planning products and organizing their
community-based distribution, and improving health
providers’ technical skills [6].
Demand generation interventions are generally classified
into three categories: interpersonal communications, mass
media, and innovative financing approaches [5, 7]. Inter-
personal communications include group discussions, one-
on-one discussions, small group sessions, facilitator-led
curricula, and health worker counselling. The aim of this
category of interventions is to change people’s attitudes
toward family planning. In one study of an interven-
tion in Nigeria consisting mainly of interpersonal
communication (entertainment education), an increase
in modern contraceptive use was reported in each of
the intervention sites, ranging from 2.3 to 15.5 %,
3 years after implementation [8].
Mass media interventions are aimed at changing peo-
ple’s perceptions and attitudes toward family planning
and increasing their knowledge about sexual and repro-
ductive health. For instance, a multi-country study
(Nigeria, India, Kenya, Senegal) reported an increase in
modern contraceptive use after implementation of a
television program conveying family planning messages
(OR = 1.24; p < 0.05) [6].
Innovative financing interventions to generate demand
include vouchers, cash transfers, social transfers, and
micro-credit designed to improve access to and use of
modern contraception methods [5]. A study in Pakistan
reported a 28.4 % increase in modern contraception use
and an overall contraceptive rate of 19.6 % after imple-
mentation of a voucher scheme; the intervention in-
cluded social franchising (training private providers and
social marketing). The sample in that study, conducted
in four districts in Punjab and Sindh provinces, con-
sisted of 4992 women of reproductive age [9].
Demand generation interventions have had positive ef-
fects on indicators related to sexual and reproductive
health in terms of use of reproductive health services
(e.g., family planning) and increased knowledge about
human immunodeficiency virus (HIV) and sexually
transmitted infections (STIs) [10, 11]. However, the het-
erogeneity in the designs of studies assessing demand-
side interventions and the lack of evidence on indicators
used to measure the outcomes of such interventions
make it difficult to draw overall conclusions about their
effectiveness [5, 11].
As part of its family planning strategy, the United Na-
tions Population Fund (UNFPA) has commissioned this
systematic review on the effectiveness, cost-effectiveness,
and impact of family planning demand generation inter-
ventions in LMICs. The results of the systematic review
will be disseminated to UNFPA program countries and
will contribute to the development of a guidance docu-
ment and programmatic tools for planning, implement-
ing, and evaluating demand generation interventions in
family planning.
Methods/design
Objectives and research questions
The objectives of the systematic review will be as fol-
lows: (1) to synthesize evidence on the impacts and costs
of family planning demand generation interventions and
on their effectiveness in improving access and uptake of
modern contraception use; and (2) to identify the indica-
tors used to assess effectiveness, cost-effectiveness, and
impacts of demand generation interventions.
The research questions are as follows: what are the im-
pacts of family planning demand generation interventions
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on indicators of contraceptive use? What are the direct
and indirect costs of such interventions?
Design
We will conduct a systematic review focused on pub-
lic health and health promotion [12]. The proposed
knowledge synthesis approach is the most suitable for
the type of interventions under study. Indeed, demand
generation interventions in family planning can be
considered public health interventions because: (1)
they are interconnected with the context in which
they are implemented; (2) their conditions of imple-
mentation are heterogeneous; and (3) they have an
important social dimension, in that they promote sex-
ual health [13]. Given that public health interventions
are assessed using a variety of study designs, our sys-
tematic review will need to be adjusted to the several
types of study designs. Our review will follow the
phases of the flow diagram developed by the Pre-
ferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) Group (Fig. 1) [14].
Information sources and search strategy
A search strategy will be developed with a librarian ex-
pert at the University of Montreal Hospital Research
Centre (CRCHUM) [15]. Bibliographic search filters will
be used to identify works published between 1970 and
2015 in English and French. We will begin with the
1970s, as that is when most national voluntary family
planning programs were implemented to reduce population
growth in developing countries, and in fact, 1970–1990 is
considered to be when the “reproductive revolution” oc-
curred in LMICs everywhere, with the exception of sub-
Saharan Africa [16].
We will use a combination of medical subject headings
(mesh terms) and text words to develop our search strat-
egy. The search strategy will cover four main conceptual
categories: (1) low- and middle-income countries, (2)
family planning, (3) use and knowledge of contraceptive
methods, and (4) interventions. The detailed search
strategy is provided in Appendix 1. We will search
the following databases: Embase (OVID interface,
1974–2015) CINAHL, Ovid Medline (OVID interface,
1946–2015), Medline (PubMed interface, 1975–2015),
and the Cochrane Database of Systematic Reviews.
Fig. 1 PRISMA flow diagram [14]
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For the gray literature, the following databases will be
screened: Google Scholar, Social Care Online, and the
National Institute for Health and Care Excellence
(NICE). Websites of institutions active in maternal
and reproductive health and the bibliographies of po-
tential articles will be used as additional sources of
data.
The references will be managed with EndNote soft-
ware. Two members of the team (BL, AZ) will retrieve
the titles and abstracts of articles independently. Any
discrepancy will be resolved with the whole team.
Definition of demand generation interventions
Family planning programs consist of complex interven-
tions that combine enabling environments (policies,
strategies, financing, etc.) with demand- and supply-side
interventions. In this review, as commissioned by the
UNFPA, we will focus on demand generation interven-
tions, which can be defined in several ways. Regardless
of how they are defined, demand generation interven-
tions are often heterogeneous and include, but are not
limited to the following: “development of advocacy ma-
terials for family planning; dissemination of appropriate
messages for family planning by community health
workers; advocacy on family planning at the community
levels to involve the formal and informal leaders;
sensitization and awareness creation through community
radio, radio drama, television drama, etc.; targeting of
special groups including male motivation etc., in the
promotion of contraceptives; training of community
health/extension workers and others for promotion of
family planning; and social marketing of modern contra-
ceptives” [17] and innovative financing for demand gen-
eration (such as vouchers and conditional cash transfer).
Inclusion criteria for studies
In terms of minimum inclusion criteria, we will retain
studies that:
(1)Looked at family planning interventions and
evaluated changes in outcomes that were
attributable to the program;
(2)Dealt with demand-side activities, even if supply-side
activities were also studied; while recognizing that
family planning interventions are complex and gen-
erally combine both, our focus in this review will be
on demand activities, and when both are covered,
we will retain only articles in which the results for
demand and supply activities are presented separ-
ately and will exclude articles in which they are
mixed;
(3)Were conducted in LMICs, as defined by the World
Bank [18];
(4)Were related to any or all populations with potential
for sexual activity, i.e., women, men, married,
unmarried, and adolescents: and
(5)In terms of study designs, used randomized
controlled trials (RCTs) or cluster randomized trials
(CRTs) or were quasi-experimental, e.g., controlled
before–after studies (CBAs) and interrupted time
series studies (ITSs) will be targeted. The compara-
tor groups for the experimental and quasi-
experimental designs to be considered are no inter-
vention or other intervention and pre- and post-
tests.
In terms of exclusion criteria, we will not retain stud-
ies that:
(1)Included only supply-side activities for family plan-
ning and contraceptive use;
(2)Did not focus on family planning but more largely
on youth reproductive health, HIV–AIDS, and STIs;
(3)Aimed to assess the feasibility or acceptability of
reproductive health programs; and
(4)Only described interventions, with no analysis of
program impacts.
Data collection process
We will extract data pertaining to the studies’ character-
istics (authors, institutions, country, publication, study
design, characteristics of the participants, sample size,
description of the interventions) and outcomes/indica-
tors data related to costs, effectiveness, cost-
effectiveness, and impacts (Table 1).
Two members of the team (BL, AZ) will extract the
data independently and compare them. If there is dis-
agreement, a decision will be taken by the whole team.
Quality assessment
Two members of the research team will also assess
the quality of the studies independently. Any discrep-
ancies will be discussed by the whole team, who will
resolve them together.
Evaluating the quality of articles documenting pub-
lic health programs can be challenging due to the
variety of study designs used. As such, the evaluation
tool used will depend on the study design. For RCTs,
we will use the Cochrane Collaboration’s Risk of Bias
Tool (CCRBT), and for quasi experimental study de-
signs (CBA, ITS), we will use the criteria of the
Cochrane Effective Practice and Organization of Care
(EPOC) Group [19]. Thus, the articles will be catego-
rized into three categories of quality: high, medium,
and low.
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Data synthesis
If appropriate, a meta-analysis will be conducted using
the Cochrane Group’s Review Manager Software (Rev-
Man 5.3) [20]. Analysis will involve comparing odd ratio
(OR) Outcomes will be compared between control and
intervention groups. For dichotomous data, we will use
ORs with 95 % confidence intervals (CI) as measures of
effect. Standardized mean difference (SMD) will be used
for continuous data using 95 % CIs as measures of effect
size.
To evaluate study designs such as interrupted time
series, we will use auto regressive integrated moving
average (ARIMA) models, including them in the meta-
analysis [21]. Because the validity of a meta-analysis de-
pends on the exploration of the heterogeneity of results,
we will pay particular attention to this element. We will
use the I2 index and Q statistic to assess heterogeneity,
adopting a 50 % standard as recommended by Cochrane
guidelines [19].
In the meta-analysis, two statistical procedures could
be used: fixed or random effects. Fixed effects model as-
sumes any difference in effect size in the meta-analysis is
due only to sampling error. In that model, all studies
share a common mean. In contrast, random effects
model assumes variation not only in the sampling, but
also in how studies are conducted [22]. Because we
expect considerable variation in the studies retained, we
will use random effects to gain a better understanding of
the results.
If heterogeneity exceeds 50 %, we will undertake sub-
group analyses and meta-regression. For example, we
might conduct subgroup analyses related to study de-
signs, year of publication, settings, and types of interven-
tion. However, if we find too much heterogeneity in
outcomes measures, as has been found in several sys-
tematic reviews, we will present the results narratively
[5, 23–26].
The report will be presented in a format geared toward
knowledge users [27] as well as to the PRISMA state-
ment and checklist [14]. This protocol is registered in
PROSPERO (CRD 42015017549).
Discussion
We know what works to improve outcomes related to
family planning programs. However, we do not yet
know how to do it effectively [28, 29]. By increasing
knowledge on the cost-effectiveness of demand gener-
ation interventions, this systematic review will provide
evidence to support the improvement of family plan-
ning programs. It will also identify knowledge gaps
regarding family planning interventions.
Recommendations will be made to the UNFPA and
partner agencies in the Family Planning 2020 commu-
nity. This review will also contribute to the development
of a guidance document and programmatic tools for
planning, implementing, and evaluating demand gener-
ation interventions in family planning as part of the
UNFPA Global Programme to Enhance Reproductive
Health Commodity Security (GPRHCS). The program
aims to “ensure a secure, steady and reliable supply of
quality reproductive health commodities and improve
access and use” by strengthening national health systems
and services [3, p. 9].
The evidence gathered from this review will also be
used to enhance the effectiveness of family planning pro-
grams in LMICs. Family planning is considered to be a
primary prevention measure and an efficient public
health intervention [28]. Indeed, family planning is
closely entwined with maternal health. The use of mod-
ern contraceptive methods could prevent up to one third
of maternal deaths. Effective family planning programs
are a critical means of empowering women and adoles-
cent girls, improving human capital, reducing depend-
ency ratios, reducing maternal (through mortality
depletion) and child (through birth spacing and im-
proved nutrition) mortality, and achieving demographic
dividends in low- and middle-income countries [28].
Nevertheless, family planning remains underused and
still often neglected by some governments [28, 29]. No
country in the world has achieved sustainable
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development without meeting a high percentage of the
demand for modern contraception [30]. Indeed, in a re-
cent working paper, Kendall [31] noted that family plan-
ning in LMICs has one of the greatest coverage gaps
globally. Since 2000, the demand for family planning has
risen very slowly [32]. In WHO’s Countdown to 2015 re-
port, the median coverage for the 37 countries with data
is 61 %, with a range of 15 % (Chad) to 95 % (Vietnam)
[33]. Kendall [31] pointed to family planning as an area
of critical maternal health knowledge gaps in LMICs for
post-2015. As such, increasing knowledge on family
planning remains a global health priority for the agenda
beyond 2015. Lastly, our results will be published in pol-
icy briefs as well as in a peer-reviewed scientific journal.
Appendix 1
Search strategy on effect of demand generation
interventions on uptake and use of modern
contraceptives in LMIC
Group 1 (concept: low- and middle-income)
“Afghanistan”[Mesh] OR “Libya”[Mesh] OR “Alba-
nia”[Mesh] OR “Macedonia Republic”[Mesh] OR “Alger-
ia”[Mesh] OR “Madagascar”[Mesh] OR “American
Samoa”[Mesh] OR “Malawi”[Mesh] OR “Angola”[Mesh]
OR “Malaysia”[Mesh] OR “Argentina”[Mesh] OR “Indian
Ocean Islands”[Mesh] OR “Armenia”[Mesh] OR “Mali”
[Mesh] OR “Azerbaijan”[Mesh] OR “Micronesia”[Mesh]
OR “Bangladesh”[Mesh] OR “Mauritania”[Mesh] OR
“Republic of Belarus”[Mesh] OR “Mauritius”[Mesh] OR
“Belize”[Mesh] OR “Mexico”[Mesh] OR “Benin”[Mesh]
OR “Bhutan”[Mesh] OR “Moldova”[Mesh] OR “Bolivia”
[Mesh] OR “Mongolia”[Mesh] OR “Bosnia-Herzegovina”
[Mesh] OR “Montenegro”[Mesh] OR “Botswana”[Mesh]
OR “Morocco”[Mesh] OR “Brazil”[Mesh] OR “Mozambi-
que”[Mesh] OR “Bulgaria”[Mesh] OR “Myanmar”[Mesh]
OR “Burkina Faso”[Mesh] OR “Namibia”[Mesh] OR “Bur-
undi”[Mesh] OR “Nepal”[Mesh] OR “Nicaragua”[Mesh]
OR “Cambodia”[Mesh] OR “Niger”[Mesh] OR “Camer-
oon”[Mesh] OR “Nigeria”[Mesh] OR “Central African
Republic”[Mesh] OR “Pakistan”[Mesh] OR “Chad”[Mesh]
OR “Palau”[Mesh] OR “China”[Mesh] OR “Panama”
[Mesh] OR “Colombia”[Mesh] OR “Papua New Guinea”
[Mesh] OR “Comoros”[Mesh] OR “Paraguay”[Mesh] OR
“Democratic Republic of the Congo”[Mesh] OR “Congo”
[Mesh] OR “Peru”[Mesh] OR “Philippines”[Mesh] OR
“Costa Rica”[Mesh] OR “Romania”[Mesh] OR “Cote
d'Ivoire“[Mesh] OR “Rwanda”[Mesh] OR “Cuba”[Mesh]
OR “Samoa”[Mesh] OR “Djibouti”[Mesh] OR “Atlantic
Islands”[Mesh] OR “Dominica”[Mesh] OR “Senegal”
[Mesh] OR “Dominican Republic”[Mesh] OR “Serbia”
[Mesh] OR “Ecuador”[Mesh] OR “Seychelles”[Mesh] OR
“Egypt”[Mesh] OR “Sierra Leone”[Mesh] OR “El Salva-
dor”[Mesh] OR “Melanesia”[Mesh] OR “Eritrea”[Mesh]
OR “Somalia”[Mesh] OR “Ethiopia”[Mesh] OR “South
Africa”[Mesh] OR “Fiji”[Mesh] OR “Sudan”[Mesh] OR
“Gabon”[Mesh] OR “Sri Lanka”[Mesh] OR “Gambia”
[Mesh] OR “Saint Lucia”[Mesh] OR “Georgia”[Mesh] OR
“Saint Vincent and the Grenadines”[Mesh] OR “Ghana”
[Mesh] OR “Grenada”[Mesh] OR “Suriname”[Mesh] OR
“Guatemala”[Mesh] OR “Swaziland”[Mesh] OR “Guinea”
[Mesh] OR “Syria”[Mesh] OR “Guinea-Bissau”[Mesh] OR
“Tajikistan”[Mesh] OR “Guyana”[Mesh] OR “Tanzania”
[Mesh] OR “Haiti”[Mesh] OR “Thailand”[Mesh] OR
“Honduras”[Mesh] OR “East Timor”[Mesh] OR “Hun-
gary”[Mesh] OR “Togo”[Mesh] OR “India”[Mesh] OR
“Tonga”[Mesh] OR “Indonesia”[Mesh] OR “Tunisia”
[Mesh] OR “Iran”[Mesh] OR “Turkey”[Mesh] OR
“Iraq”[Mesh] OR “Turkmenistan”[Mesh] OR “Jamaica”
[Mesh] OR “Micronesia”[Mesh] OR “Jordan”[Mesh] OR
“Uganda”[Mesh] OR “Kazakhstan”[Mesh] OR “Ukrai-
ne”[Mesh] OR “Kenya”[Mesh] OR “Uzbekistan”[Mesh]
OR “Vanuatu”[Mesh] OR “Korea”[Mesh] OR “Venezue-
la”[Mesh] OR “Kosovo”[Mesh] OR “Vietnam”[Mesh] OR
“Kyrgyzstan”[Mesh] OR “Middle East”[Mesh] OR
“Yemen”[Mesh] OR “Lebanon”[Mesh] OR “Lesotho”
[Mesh] OR “Zambia”[Mesh] OR “Zimbabwe”[Mesh] OR
“Liberia”[Mesh] OR “Developing Countries”[Mesh] OR
Afghanistan[Title/Abstract] OR Albania[Title/Abstract]
OR Algeria[Title/Abstract] OR American Samoa[Title/
Abstract] OR Angola[Title/Abstract] OR Argentina[Title/
Abstract] OR Armenia[Title/Abstract] OR Azerbaijan
[Title/Abstract] OR Bangladesh[Title/Abstract] OR Belar-
us[Title/Abstract] OR Belize[Title/Abstract] OR Benin[Ti-
tle/Abstract] OR Bhutan[Title/Abstract] OR Bolivia[Title/
Abstract] OR Bosnia Herzegovina[Title/Abstract] OR
Botswana[Title/Abstract] OR Brazil[Title/Abstract] OR
Bulgaria[Title/Abstract] OR Burkina Faso[Title/Abstract]
OR Burundi[Title/Abstract] OR Cabo Verde[Title/Ab-
stract] OR Cambodia[Title/Abstract] OR Cameroonek[Ti-
tle/Abstract] OR Central African Republic[Title/Abstract]
OR Chad[Title/Abstract] OR China[Title/Abstract] OR
Colombia[Title/Abstract] OR Comoros[Title/Abstract]
OR Congo[Title/Abstract] OR Costa Rica[Title/Abstract]
OR Cote d'Ivoire[Title/Abstract] OR Cuba[Title/Abstract]
OR Djibouti[Title/Abstract] OR Dominicaek[Title/Ab-
stract] OR Dominican Republic[Title/Abstract] OR Ecua-
dor[Title/Abstract] OR Egypt[Title/Abstract] OR El
Salvador[Title/Abstract] OR Eritreaek[Title/Abstract]
OR Ethiopia[Title/Abstract] OR Fiji[Title/Abstract]
OR Gabon[Title/Abstract] OR Gambia[Title/Abstract]
OR Georgia[Title/Abstract] OR Ghana[Title/Abstract] OR
Grenada[Title/Abstract] OR Guatemala[Title/Abstract] OR
Guinea[Title/Abstract] OR Guinea-Bissau[Title/Abstract]
OR Guyana[Title/Abstract] OR Haiti[Title/Abstract] OR
Honduras[Title/Abstract] OR Hungary[Title/Abstract]
OR India[Title/Abstract] OR Indonesia[Title/Abstract]
OR Iran[Title/Abstract] OR Iraq[Title/Abstract] OR
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Jamaica[Title/Abstract] OR Jordan[Title/Abstract] OR
Kazakhstan[Title/Abstract] OR Kenya[Title/Abstract] OR
Kiribati[Title/Abstract] OR Korea[Title/Abstract] OR
Kosovo[Title/Abstract] OR Kyrgyz [Title/Abstract] OR
Lao PDR[Title/Abstract] OR Lebanon[Title/Abstract] OR
Lesotho[Title/Abstract] OR Liberia[Title/Abstract] OR
Libya[Title/Abstract] OR Macedonia[Title/Abstract] OR
Madagascar[Title/Abstract] OR Malawi[Title/Abstract]
OR Malaysia[Title/Abstract] OR Maldives[Title/Abstract]
OR Mali[Title/Abstract] OR Marshall Islands[Title/
Abstract] OR Mauritania[Title/Abstract] OR Mauritius
[Title/Abstract] OR Mexico[Title/Abstract] OR Micronesia
[Title/Abstract] OR Moldova[Title/Abstract] OR Mongolia
[Title/Abstract] OR Montenegro[Title/Abstract] OR
Morocco[Title/Abstract] OR Mozambique[Title/Abstract]
OR Myanmar[Title/Abstract] OR Namibia[Title/Abstract]
OR Nepal[Title/Abstract] OR Nicaragua[Title/Abstract]
OR Niger[Title/Abstract] OR Nigeria[Title/Abstract] OR
Pakistan[Title/Abstract] OR Palau[Title/Abstract] OR
Panama[Title/Abstract] OR Papua New Guinea[Title/
Abstract] OR Paraguay[Title/Abstract] OR Peru[Title/
Abstract] OR Philippines[Title/Abstract] OR Romania[Title/
Abstract] OR Rwanda[Title/Abstract] OR Samoa[Title/
Abstract] OR Sao Tome[Title/Abstract] OR Senegal[Title/
Abstract] OR Serbia[Title/Abstract] OR Seychelles[Title/
Abstract] OR Sierra Leone[Title/Abstract] OR Solomon
Islands[Title/Abstract] OR Somalia[Title/Abstract] OR
South Africa[Title/Abstract] OR South Sudan[Title/Ab-
stract] OR Sri Lanka[Title/Abstract] OR St. Lucia[Title/
Abstract] OR St. Vincent the Grenadines[Title/Abstract]
OR Sudan[Title/Abstract] OR Suriname[Title/Abstract]
OR Swaziland[Title/Abstract] OR Syrian Arab Republic
[Title/Abstract] OR Tajikistan[Title/Abstract] OR Tanzania
[Title/Abstract] OR Thailand[Title/Abstract] OR Timor-
Leste[Title/Abstract] OR Togo[Title/Abstract] OR Tonga
[Title/Abstract] OR Tunisia[Title/Abstract] OR Turkey
[Title/Abstract] OR Turkmenistan[Title/Abstract] OR
Tuvalu[Title/Abstract] OR Uganda[Title/Abstract] OR
Ukraine[Title/Abstract] OR Uzbekistan[Title/Abstract]
OR Vanuatu[Title/Abstract] OR Venezuela[Title/Abstract]
OR Vietnam[Title/Abstract] OR Gaza[Title/Abstract] OR
Yemen[Title/Abstract] OR Zambia[Title/Abstract] OR
Zimbabwe[Title/Abstract] OR “Developing Countr*”[Title/
Abstract] or middle income countr* or low income
countr*).
AND
Groupe 2 (concept: family planning)
– birth control[Title/Abstract] OR “Family Planning
Services”[Mesh:NoExp] OR “Family Planning Poli
cy”[Mesh:NoExp] OR “Contraception Behavior”
[Mesh:NoExp] OR “Contraception/psychology
[Mesh:NoExp] OR “Contraception/utilization”
[Mesh:NoExp] OR family planning[Title/Abstract]
OR contracepti*[Title/Abstract] OR planned preg
nanc*[Title/Abstract] OR birth prevention[Title/
Abstract] OR prevent* pregnanc*[Title/Abstract]
OR “Birth Intervals” [Mesh:NoExp] OR birth inter
val*[Title/Abstract] OR birth spacing[Title/Abs
tract] OR pregnancy interval[Title/Abstract] OR
pregnancy spacing[Title/Abstract]
AND






Health services needs and demand






Group 4 (concept: intervention)
– Quasi experimental studies




AIDS: acquired immunodeficiency syndrome; ARIMA: auto regressive
regressive integrated moving average; CBA: controlled before–after studies;
CCRBT: Cochrane Collaboration’s Risk of Bias Tool; CI: confidential intervals;
CRCHUM: University of Montreal Hospital Research Centre; CRCT: cluster
randomized controlled trials; GPRHCS: Global Programme Reproductive
Health Commodity Security; HIV: human immunodeficiency virus;
ITS: interrupted time series studies; LMIC: low–middle-income countries;
NICE: National Institute for Health and Care Excellence; RCT: randomized
controlled trials; RR: relative risk; SMD: standardized mean difference;
STI: sexually transmitted infections; UNFPA: United Nations Population Fund;
WHO: World Health Organization.
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